| Filed | Form | Filer | Stake | Shares | |
|---|---|---|---|---|---|
| 2026-08-27 | SCHEDULE 13D/A | Sarissa Capital Management LP | 6.09% | 25,743,900 | view → |
| 2023-09-05 | SC | Sarissa Capital Management LP | — | — | view → |
| 2023-02-27 | SC | Sarissa Capital Management LP | — | — | view → |
| 2023-02-21 | SC | Sarissa Capital Management LP | — | — | view → |
| 2023-01-11 | SC | Sarissa Capital Management LP | — | — | view → |
| 2022-10-11 | SC | Sarissa Capital Management LP | — | — | view → |
| Filed | Form | Issuer | Stake | Shares | |
|---|---|---|---|---|---|
| 2026-08-27 | SCHEDULE 13D/A | Amarin Corporation PLC/UK | 6.09% | 25,743,900 | view → |
| 2025-03-17 | SCHEDULE | Innoviva, Inc. INVA | 4.70% | 2,966,022 | view → |
| 2025-03-07 | SCHEDULE | Innoviva, Inc. INVA | 8.40% | 5,237,161 | view → |
| 2023-09-05 | SC | AMARIN CORP PLC\UK AMRN | — | — | view → |
| 2023-06-21 | SC | Alkermes plc. ALKS | — | — | view → |
| 2023-06-12 | SC | Alkermes plc. ALKS | — | — | view → |
| 2023-06-12 | SC | Sarissa Capital Management LP | — | — | view → |
| 2023-02-27 | SC | AMARIN CORP PLC\UK AMRN | — | — | view → |
| 2023-02-21 | SC | AMARIN CORP PLC\UK AMRN | — | — | view → |
| 2023-01-11 | SC | AMARIN CORP PLC\UK AMRN | — | — | view → |
| 2022-10-11 | SC | AMARIN CORP PLC\UK AMRN | — | — | view → |
| 2022-07-06 | SC | Alkermes plc. ALKS | — | — | view → |
| 2022-01-10 | SC | Alkermes plc. ALKS | — | — | view → |
| 2021-11-19 | SC | Alkermes plc. ALKS | — | — | view → |
| 2021-09-10 | SC | Alkermes plc. ALKS | — | — | view → |
| 2021-05-27 | SC | Alkermes plc. ALKS | — | — | view → |
| 2021-05-25 | SC | Innoviva, Inc. INVA | — | — | view → |
| 2021-03-01 | SC | IRONWOOD PHARMACEUTICALS INC IRWD | — | — | view → |
| 2021-02-12 | SC | Iterum Therapeutics plc ITRMF | — | — | view → |
| 2020-12-14 | SC | Innoviva, Inc. INVA | — | — | view → |
Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.
See pricing →